Ajovy 225 MG/1.5 ML syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB26FRHJA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,494
Award facts
- Contract value 100% obligated
- $1,493.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,493.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY 225 MG/1.5 ML syringes on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-competitive delivery order was issued without a set-aside designation and is performable at the contractor's facility in Conshohocken, Pennsylvania. AJOVY is a prescription medication used to treat chronic migraine, representing the type of specialized pharmaceutical product that AmerisourceBergen regularly supplies through its federal contracts.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement establishes a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FRHJA?
SPE2DB26FRHJA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FRHJA worth?
The government has obligated $1,494 on SPE2DB26FRHJA.
Is contract SPE2DB26FRHJA an order under another contract?
Yes. SPE2DB26FRHJA is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB26FRHJA competed?
The extent of competition for SPE2DB26FRHJA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award